The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

TapImmune, Inc. - Immunotherapy Company Focused on Developing Vaccine Technologies for the Treatment of Cancer and Infectious Disease

SNNLive spoke with Glynn Wilson, Ph.D., Chairman and CEO of TapImmune Inc. (OTCQB: TPIV) at the Healthcare Media Day 2015 in San Francisco, CA.

Share With

Monday, March 30, 2015

   

© 2017 Stock News Now